Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 1.97 is 49% below its 5-year average of 3.85, near the low end of its 5-year range (0.40–20.65).
As of the fiscal period ended Tuesday, June 30, 2026. 2.14% above its 12-month average of 1.93.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 1.97.
QUICK RATIO (ACID-TEST)
1.97
QUICK RATIO (ACID-TEST) AVG TTM
1.93
QUICK RATIO (ACID-TEST) AVG 3Y
1.27
QUICK RATIO (ACID-TEST) AVG 5Y
3.85
QUICK RATIO (ACID-TEST) AVG 10Y
7.40
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
+2.14%
CURRENT VS 3Y AVG
+55.20%
CURRENT VS 5Y AVG
-48.78%
CURRENT VS 10Y AVG
-73.34%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.35
median of 871 covered companies
CURRENT VS SECTOR MEDIAN
-41.14%
vs the sector median at left
Mustang Bio, Inc.
Market Cap
$3.49M
Quick Ratio (Acid-Test)
1.97
TTM Avg
1.93
3Y Avg
1.27
5Y Avg
3.85
Market Cap
$3.50M
Quick Ratio (Acid-Test)
0.08
TTM Avg
0.52
3Y Avg
0.43
5Y Avg
0.47
Market Cap
$3.53M
Quick Ratio (Acid-Test)
3.73
TTM Avg
3.25
3Y Avg
4.33
5Y Avg
4.33
Market Cap
$3.63M
Quick Ratio (Acid-Test)
0.82
TTM Avg
1.40
3Y Avg
1.07
5Y Avg
0.94
Market Cap
$3.65M
Quick Ratio (Acid-Test)
2.01
TTM Avg
0.91
3Y Avg
1.26
5Y Avg
1.78
Market Cap
$3.30M
Quick Ratio (Acid-Test)
1.10
TTM Avg
5.81
3Y Avg
5.76
5Y Avg
3.90
Market Cap
$3.28M
Quick Ratio (Acid-Test)
8.13
TTM Avg
4.58
3Y Avg
2.68
5Y Avg
3.19
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Mustang Bio, Inc. (MBIO) | $3.49M | 1.97 | 1.93 | 1.27 | 3.85 |
| Eocene Ltd. (EOCN)vs › | $3.50M | N/A | N/A | N/A | N/A |
| Moolec Science S.A. (MLEC)vs › | $3.50M | 0.08 | 0.52 | 0.43 | 0.47 |
| Cadrenal Therapeutics, Inc. Common Stock (CVKD)vs › | $3.53M | 3.73 | 3.25 | 4.33 | 4.33 |
| WORK Medical Technology Group Ltd. Class A (WOK)vs › | $3.63M | 0.82 | 1.40 | 1.07 | 0.94 |
| Ernexa Therapeutics Inc. (ERNA)vs › | $3.65M | 2.01 | 0.91 | 1.26 | 1.78 |
| Evogene Ltd. (EVGN)vs › | $3.65M | 3.54 | 2.77 | 4.28 | 5.12 |
| Nexalin Technology, Inc. (NXL)vs › | $3.30M | 1.10 | 5.81 | 5.76 | 3.90 |
| Paranovus Entertainment Technology Ltd. (PAVS)vs › | $3.28M | 8.13 | 4.58 | 2.68 | 3.19 |
| MBody AI Ltd. (MBAI)vs › | $3.25M | 0.05 | 0.10 | 7.85 | 8.89 |
Quick Ratio
1.97
Excludes inventory
Current Ratio
1.97
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 1.97 |
| 2026-03-31 | 2.10 |
| 2025-12-31 | 2.22 |
| 2025-09-30 | 2.05 |
| 2025-06-30 | 1.30 |
| 2025-03-31 | 1.34 |
| 2024-12-31 | 0.68 |
| 2024-09-30 | 0.40 |
| 2024-06-30 | 0.46 |
| 2024-03-31 | 0.53 |
| 2023-12-31 | 0.74 |
| 2023-09-30 | 0.96 |
| 2023-06-30 | 1.75 |
| 2023-03-31 | 4.83 |
| 2022-12-31 | 5.22 |
| 2022-09-30 | 6.97 |
| 2022-06-30 | 9.96 |
| 2022-03-31 | 11.51 |
| 2021-12-31 | 10.33 |
| 2021-09-30 | 11.66 |
| 2021-06-30 | 20.65 |
| 2021-03-31 | 19.89 |
| 2020-12-31 | 10.46 |
| 2020-09-30 | 9.91 |
| 2020-06-30 | 5.85 |
| 2020-03-31 | 5.75 |
| 2019-12-31 | 8.12 |
| 2019-09-30 | 11.82 |
| 2019-06-30 | 13.10 |
| 2019-03-31 | 5.64 |
| 2018-12-31 | 6.25 |
| 2018-09-30 | 10.32 |
| 2018-06-30 | 13.09 |
| 2018-03-31 | 10.45 |
| 2017-12-31 | 16.99 |
| 2017-09-30 | 24.26 |
| 2017-06-30 | 15.51 |
| 2017-03-31 | 92.51 |
| 2016-12-31 | 8.53 |
| 2016-09-30 | 2.28 |
| 2016-06-30 | 0.00 |
| 2016-03-31 | 0.00 |
| 2015-12-31 | 0.00 |
| 2015-09-30 | 0.00 |
